Bombay Oxygen Investments Ltd

Know More
NSEBSE
Stock not tradded

13102.35102.35 (0.79%)

12:00 AM,1st Dec 2023

BSE : 509470

NSE :

Sector : Financials

ISIN Code : INE01TL01014

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Dec 01 2023 | 12:00 AM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

100

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Bombay Oxygen Investments Ltd

Bombay Oxygen Investment Limited (Formerly known as Bombay Oxygen Corporation) was incorporated in October 1960 to manufacture and market industrial gases. The Company's name was changed to Bombay Oxygen Investment Limited w.e.f. 3rd October 2018. The Company is a Non-Banking Financial Company (NBFC) registered with the Reserve Bank of India. Its manufacturing facilities are located in Nagpur Tarapur Pune Nira Khopoli Kalwe and Mulund all in Maharashtra. The Company's primary business was manufacturing and supplying of Industrial Gases which discontinued from 1st August 2019. The Company owns substantial financial investments in the form of shares mutual funds & other financial securities and the income from such financial investments is the source of revenue of the Company.The Company has a collaboration with General Electrodes and Equipments Germany. It had entered into an agreement for procuring engineering services from Messer AGS Gmbh. In Mar.'95 it installed a capacity of 2.37 lac cu mtr for the manufacture of oxygen. The company manufactures various industrial gases such as oxygen nitrogen argon compressed air acetylene and medicinal oxygen. Its subsidiaries -- Savita Pharmaceuticals and Raptakos Brett & Company -- are engaged in the manufacture and distribution of pharmaceuticals. The company designed and developed an indigenous cryogenic liquid oxygen pump for high-pressure gas-filling purposes. In 1996 the company disinvested in the shares of Raptakos Brett & Co. Therefore Raptakos Brett & Co as also its subsidiaries Raptakos Brett Test Laboratries and Sattva Pharmaceuticals ceased to be the company's subsidiaries.The Company commissioned its Tonnage Oxygen Plant at Kalwe during the month of June 2003. Similarly the 40 TPD Oxygen Liquiefier Plant at Kalwe got commissioned in the month of March 2005.

Bombay Oxygen Investments Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

196

EPS - TTM (₹) [S]

2352.43

P/E Ratio (X) [S]

0.49

Face Value (₹) 100
Latest Dividend (%)15.00
Latest Dividend Date 27 Jun 2023
Dividend Yield (%) 0.11
Book Value Share (₹) [S]26735.62
P/B Ratio (₹) [S]0.49
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

12806.00

13298.00

Week Low/High

12402.00

13298.00

Month Low/High

11800.00

13738.00

Year Low/High

9811.30

16910.00

All time Low/High

150.00

29700.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week1.76%%2.292.39%
1 Month6.52%%6.126.73%
3 Month9.96%%3.204.28%
6 Month21.93%%8.099.63%
1 Year21.32%%6.637.74%
3 Year23.37%%51.1254.61%

Company Info

Company Information

Chairman (Non-Executive) : Shyam M Ruia

Independent Director : Mohan Bir Singh

Independent Director : Nirmal P Jhunjhunwala

Independent Director : ARUNA KANTIKUMAR KANORIA

Company Sec. & Compli. Officer : Sangeeta Rohit Naik

Whole-time Director : Hema Reganathan

Director : Vikas Mukesh Jain

Registered Office: 22/B Mittal Tower, 210 Nariman Point,Mumbai,Maharashtra-400021 Ph: 91-022-66107503-08

Email:bomoxy@mtnl.net.in

URL:http://www.bomoxy.com